What is pharmacovigilance and how does it relate to social construction?

What is pharmacovigilance and how does it relate to social construction?

• A. It is the marketing science for pharmaceuticals and does not consider safety
• B. It is the science of detecting adverse drug effects; social factors influence safety reporting and trust
• C. It is a purely laboratory concept with no patient interaction
• D. It predicts drug efficacy solely based on randomized trials

Answer: (B)

Pharmacovigilance is the ongoing monitoring of medicines to identify, assess, and prevent adverse drug reactions. Its relation to social construction comes from the idea that safety signals don’t emerge purely as objective facts; they are produced and interpreted through social processes. Clinicians, patients, regulators, and the media all participate in reporting, communicating, and shaping what counts as an adverse effect, how trustworthy the information is, and whether a signal leads to action. Factors like cultural norms, trust in healthcare systems, accessibility of reporting channels, and the presence of stigma or fear about side effects all influence whether adverse events are reported and how they are perceived. So, the science focuses on detecting adverse effects, while social factors shape the reporting, interpretation, and trust that determine how safety information is constructed and acted upon. The other descriptions miss this core idea: pharmacovigilance isn’t just marketing or lab work, and it isn’t about predicting efficacy from trials alone.

Pharmacovigilance is the ongoing monitoring of medicines to identify, assess, and prevent adverse drug reactions. Its relation to social construction comes from the idea that safety signals don’t emerge purely as objective facts; they are produced and interpreted through social processes. Clinicians, patients, regulators, and the media all participate in reporting, communicating, and shaping what counts as an adverse effect, how trustworthy the information is, and whether a signal leads to action. Factors like cultural norms, trust in healthcare systems, accessibility of reporting channels, and the presence of stigma or fear about side effects all influence whether adverse events are reported and how they are perceived. So, the science focuses on detecting adverse effects, while social factors shape the reporting, interpretation, and trust that determine how safety information is constructed and acted upon. The other descriptions miss this core idea: pharmacovigilance isn’t just marketing or lab work, and it isn’t about predicting efficacy from trials alone.